Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake
Date Insider Transaction Shares Price Value Owned after
2026-10-26 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +7,866 $25.01 $197K 62,511
2026-10-26 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −7,866 $37.69 $296K 54,645
2026-10-26 Gheuens Sarah Chief Medical Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −7,866 16,275
2026-10-22 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +500 $25.01 $13K 55,145
2026-10-22 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −500 $37.52 $19K 54,645
2026-10-22 Gheuens Sarah Chief Medical Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −500 24,141
2026-10-21 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +1,489 $25.01 $37K 56,134
2026-10-21 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −1,489 $37.53 $56K 54,645
2026-10-21 Gheuens Sarah Chief Medical Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −1,489 24,641
2026-08-04 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −30,000 $30.48 $914K 54,645
2026-07-01 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +8,375 88,652
2026-07-01 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −4,007 $37.56 $151K 84,645
2026-07-01 Gheuens Sarah Chief Medical Officer Exercise or conversion · Restricted stock units 10b5-1 −8,375 0
2026-06-18 Gheuens Sarah Chief Medical Officer Exercise or conversion · Performance share units −3,000 9,000
2026-06-18 Gheuens Sarah Chief Medical Officer Grant or award · Restricted stock units +3,000 3,000
2026-04-02 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +8,500 83,217
2026-04-02 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −2,940 $34.71 $102K 80,277
2026-04-02 Gheuens Sarah Chief Medical Officer Exercise or conversion · Performance share units 10b5-1 −8,500 8,500
2026-03-02 Gheuens Sarah Chief Medical Officer Exercise or conversion 10b5-1 +4,000 68,795
2026-03-02 Gheuens Sarah Chief Medical Officer Sale 10b5-1 −1,187 $28.96 $34K 67,608

Page 1 of 6 · 112 trades